149 related articles for article (PubMed ID: 11360213)
1. Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia.
Uzun O; Ascioglu S; Anaissie EJ; Rex JH
Clin Infect Dis; 2001 Jun; 32(12):1713-7. PubMed ID: 11360213
[TBL] [Abstract][Full Text] [Related]
2. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and outcome for breakthrough candidaemia in patients with cancer.
Chung JW; Lee SO; Choi SH; Woo JH; Ryu J; Kim YS; Kim NJ
Mycoses; 2006 Mar; 49(2):114-8. PubMed ID: 16466444
[TBL] [Abstract][Full Text] [Related]
5. Predictors of adverse outcome from candidal infection in a tertiary care hospital.
Ben-Abraham R; Keller N; Teodorovitch N; Barzilai A; Harel R; Barzilay Z; Paret G
J Infect; 2004 Nov; 49(4):317-23. PubMed ID: 15474630
[TBL] [Abstract][Full Text] [Related]
6. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
7. Adult candidemia at a medical center in northern Taiwan: a retrospective study.
Tsai CC; Wang CC; Kuo HY; Chiang DH; Lin ML; Liu CY; Yang SP
J Microbiol Immunol Infect; 2008 Oct; 41(5):414-21. PubMed ID: 19122924
[TBL] [Abstract][Full Text] [Related]
8. The predictors of outcome in immunocompetent patients with hematogenous candidiasis.
Safdar A; Bannister TW; Safdar Z
Int J Infect Dis; 2004 May; 8(3):180-6. PubMed ID: 15109594
[TBL] [Abstract][Full Text] [Related]
9. Multiple-species candidemia in patients with cancer.
Boktour MR; Kontoyiannis DP; Hanna HA; Hachem RY; Girgawy E; Bodey GP; Raad II
Cancer; 2004 Oct; 101(8):1860-5. PubMed ID: 15386338
[TBL] [Abstract][Full Text] [Related]
10. Management of central venous catheters in patients with cancer and candidemia.
Raad I; Hanna H; Boktour M; Girgawy E; Danawi H; Mardani M; Kontoyiannis D; Darouiche R; Hachem R; Bodey GP
Clin Infect Dis; 2004 Apr; 38(8):1119-27. PubMed ID: 15095217
[TBL] [Abstract][Full Text] [Related]
11. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for breakthrough candidemia.
Nucci M; Colombo AL
Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):209-11. PubMed ID: 11957023
[TBL] [Abstract][Full Text] [Related]
13. Candidemia in patients with diabetes mellitus: epidemiology and predictors of mortality.
Bader MS; Lai SM; Kumar V; Hinthorn D
Scand J Infect Dis; 2004; 36(11-12):860-4. PubMed ID: 15764174
[TBL] [Abstract][Full Text] [Related]
14. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
Garey KW; Rege M; Pai MP; Mingo DE; Suda KJ; Turpin RS; Bearden DT
Clin Infect Dis; 2006 Jul; 43(1):25-31. PubMed ID: 16758414
[TBL] [Abstract][Full Text] [Related]
15. Fungemia in acute leukemia patients: a single institution's experience.
Specchia G; Pastore D; Montagna MT; Carluccio P; Ciuffreda L; Rizzi R; Liso A
New Microbiol; 2004 Oct; 27(4):407-10. PubMed ID: 15646057
[TBL] [Abstract][Full Text] [Related]
16. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
17. Community-onset candidemia at a university hospital, 1995-2005.
Kung HC; Wang JL; Chang SC; Wang JT; Sun HY; Hsueh PR; Chen YC
J Microbiol Immunol Infect; 2007 Aug; 40(4):355-63. PubMed ID: 17712471
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and outcome for nosocomial breakthrough candidaemia.
Pasqualotto AC; Nedel WL; Machado TS; Severo LC
J Infect; 2006 Mar; 52(3):216-22. PubMed ID: 15936825
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of candidemia in intensive care units.
Bouza E; Muñoz P
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S87-91. PubMed ID: 19013346
[TBL] [Abstract][Full Text] [Related]
20. [Study on the morbidity and pathogens of patients with candidemia at the intensive care unit].
Yin QQ; Zhang YT; Fang Q
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 May; 29(5):464-8. PubMed ID: 18956679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
